CCL

Összesen 18 találat.
#/oldal:
Részletezés:
Rendezés:

1.

001-es BibID:BIBFORM118990
Első szerző:Attanasio, Roberto
Cím:Patients' persistent symptoms, clinician demographics and geo-economic factors are associated with choice of therapy for hypothyroidism by European thyroid specialists : The "THESIS"* collaboration (*Treatment of Hypothyroidism in Europe by Specialists, an International Survey) / Roberto Attanasio, Miloš Žarković, Enrico Papini, Endre Vezekenyi Nagy, Roberto Negro, Petros Perros, Ersin Akarsu, Maria Alevizaki, Göksun Ayvaz, Tomasz Bednarczuk, Biljana Beleslin, Eszter Berta, Miklos Bodor, Anna Maria Borissova, Mihail Boyanov, Camille Buffet, Maria-Cristina Burlacu, Jasmina Ciric, Juan J. Díez, Harald Dobnig, Valentin V. Fadeyev, Benjamin C. T. Field, Eric Fliers, Dagmar Führer, Juan Carlos Galofré, Tommi Hakala, Jan Jiskra, Peter A. Kopp, Michael Krebs, Michal Kršek, Martin Kuzma, Mikael Lantz, Ivica Lazúrová, Laurence Leenhardt, Vitaliy Luchytskiy, Francisca Marques Puga, Anne McGowan, Saara Metso, Carla Moran, Tatyana Morgunova, Dan Alexandru Niculescu, Božidar Perić, Tereza Planck, Catalina Poiana, Eyal Robenshtok, Patrick Olivier Rosselet, Marek Ruchala, Kamilla Ryom Riis, Alla Shepelkevich, Mykola D. Tronko, David Unuane, Irfan Vardarli, W. Edward Visser, Andromachi Vryonidou, Younes Ramazan Younes, Laszlo Hegedus
Dátum:2024
ISSN:1050-7256
Megjegyzések:Background. Hypothyroidism is common, however, aspects of its treatment remain controversial. Our survey aimed at documenting treatment choices of European thyroid specialists and exploring how patients' persistent symptoms, clinician demographics, and geo-economic factors relate to treatment choices. Methods. 17,247 thyroid specialists from 28 countries were invited to participate in an online questionnaire survey. The survey included respondent demographic data and treatment choices for hypothyroid patients with persistent symptoms. Geo-economic data for each country were included in the analyses. Results. The response rate was 32.9% (6,058 respondents out of 17,247 invitees). Levothyroxine (LT4) was the initial treatment preferred by the majority (98.3%). Persistent symptoms despite normal serum thyrotropin (TSH) while receiving LT4 treatment were reported to affect up to 10.0% of patients by 75.4% of respondents, while 28.4% reported an increasing such trend in the past five years. The principal explanations offered for patients' persistent symptoms were psychosocial factors (77.1%), comorbidities (69.2%), and unrealistic patient expectations (61.0%). Combination treatment with LT4 + liothyronine (LT3) was chosen by 40.0% of respondents for patients who complained of persistent symptoms despite a normal TSH. This option was selected more frequently by female thyroid specialists, with high-volume practice, working in countries with high gross national income per capita. Conclusions. The perception of patients' dissatisfaction reported by physicians seems lower than that described by hypothyroid patients in previous surveys. LT4+LT3 treatment is used frequently by thyroid specialists in Europe for persistent hypothyroid-like symptoms even if they generally attribute such symptoms to non-endocrine causes and despite the evidence of non-superiority of the combined over the LT4 therapy. Pressure by dissatisfied patients on their physicians for LT3-containing treatments is a likely explanation. The association of the therapeutic choices with the clinician demographic characteristics and geo-economic factors in Europe is a novel information and requires further investigation.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
quality of life
geoeconomics
survey
hypothyroidism
levothyroxine
triiodothyronine
Megjelenés:Thyroid. - [Epub ahead of print] (2024). -
További szerzők:Zarkovic, Milos Papini, Enrico Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Negro, Roberto Perros, Petros Akarsu, Ersin Alevizaki, Maria Ayvaz, Goksun Bednarczuk, Tomasz Beleslin, Biljana Nedeljkovic Berta Eszter (1980-) (belgyógyász) Bodor Miklós (1969-) (belgyógyász, endokrinológus) Borissova, Anna-Maria I. Boyanov, Mihail A. Buffet, Camille Burlacu, Maria-Cristina Ciric, Jasmina Díez, Juan J. Dobnig, Harald Fadeyev, Valentin Field, Benjamin C. T. Fliers, Eric Führer, Dagmar Galofré, Juan C. Hakala, Tommi Jiskra, Jan Kopp, Peter Krebs, Michael Krsek, Michal Kuzma, Martin Lantz, Mikael Lazúrová, Ivica Leenhardt, Laurence Luchytskiy, Vitaliy Marques Puga, Francisca McGowan, Anne Metso, Saara Moran, Carla Morgunova, Tatyana Niculescu, Dan Alexandru Peric, Bozidar Planck, Tereza Poiana, Catalina Robenshtok, Eyal Rosselet, Patrick Ruchaa, Marek Ryom Riis, Kamilla Shepelkevich, Alla P. Tronko, Mykola D. Unuane, David Vardarli, Irfan Visser, W. Edward Vryonidou, Andromachi Younes, Younes Ramazan Hegedüs László
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

2.

001-es BibID:BIBFORM031120
Első szerző:Bajnok László (belgyógyász)
Cím:Calculation of the radioiodine dose for the treatment of graves' hyperthyroidism : is more than seven-thousand rad target dose necessary? / Laszlo Bajnok, Emese Mezosi, Endre Nagy, Jeno Szabo, Ilona Sztojka, Jozsef Varga, Laszlo Galuska, Andras Leovey
Dátum:1999
ISSN:1050-7256
Megjegyzések:Some authors recently suggested a significant increase in the target dose of radioiodine treatment in Graves' disease. The aim of the present study was to investigate the impact of thyroid gland mass on the success rate of radioiodine treatment. For this purpose, the thyroid function of 105 consecutive Graves' patients was assessed 6 and 12 months after a 131I treatment and correlated to the gland mass. The patients were categorized according to the gland mass into small (< or = 30 g; 19 patients), medium size (31-50 g; 40 patients), and large size (> 50 g; 46 patients) groups (S, M, L groups, respectively). None of the patients received more than a 10,000-rad (100-Gy) target dose. During the calculation of administered 131I activity, late uptake measurement has also been routinely used, in addition to the usual maximal uptake parameter. The established effective half-life of 131I was highly variable (5 +/- 1.2 days; range: 2-7.6 days) and could not be predicted based on other clinical data without measuring an extended radioiodine uptake curve of the given patient. However, the correlation between the administered activity calculated from the complete set of uptake values and that of only a single late one was excellent (r = 0.99). Six months after the 131I treatment, hyperthyroidism was cured in 81% of patients with small and medium size thyroid glands, with 62% euthyroid and 19% hypothyroid ratios respectively. In the early phase of study for large goiters, the same linear mass activity function was used during calculation as in smaller glands. In these 17 patients the nonhyperthyroid result was comparable to the results of treatment of the small and medium size gland groups only after 1 year (77%), but the 6-month success rate was significantly lower (53%; p < 0.05). After obtaining these results, the usual 7000-rad target dose was increased to 8000-10,000 rad (depending on the gland mass) in another group of 29 patients with large thyroid glands that result in an acceptable 6-month success rate of 72%. In conclusion, instead of the "mCi 131I/g gland mass/maximal uptake" dose calculation, we suggest a method in which (1) the late 131I uptake measurement is taken into account and (2) for large goiters there is an additional dose adjustment, ie, increase is needed over the usual linear, size driven calculation. No overall increase of target dose over 10,000 rad is necessary if no antithyroid medication is given shortly before 131I treatment.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
egyetemen (Magyarországon) készült közlemény
Megjelenés:Thyroid 9 : 9 (1999), p. 865-869. -
További szerzők:Mezősi Emese Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Szabó Jenő (belgyógyász, endocrinologus) Sztojka Ilona Varga József (1955-) (fizikus) Galuska László (1946-) (belgyógyász, izotópdiagnoszta) Leövey András (1926-) (belgyógyász)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

3.

001-es BibID:BIBFORM105772
035-os BibID:(WoS)000891614100001 (Scopus)85144587906
Első szerző:Brito, Juan P.
Cím:A Survey on the Management of Thyroid Eye Disease Among American and European Thyroid Association Members / Brito Juan P., Nagy Endre V., Singh Ospina Naykky, Zarkovic Milos, Dosiou Chrysoula, Fichter Nicole, Lucarelli Mark J., Hegedüs Laszlo
Dátum:2022
ISSN:1050-7256
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thyroid. - 32 : 12 (2022), p. 1535-1546. -
További szerzők:Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Singh Ospina, Naykky Zarkovic, Milos Dosiou, Chrysoula Fichter, Nicole Lucarelli, Mark J. Hegedüs László
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

4.

001-es BibID:BIBFORM101221
035-os BibID:(cikkazonosító)3
Első szerző:Burlacu, Maria-Cristina
Cím:Use of thyroid hormones in hypothyroid and euthyroid patients : a THESIS* survey of Belgian specialists *THESIS: treatment of hypothyroidism in Europe by specialists: an international survey / Burlacu Maria-Cristina, Attanasio Roberto, Hegedüs Laszlo, Nagy Endre V., Papini Enrico, Perros Petros, Sawadogo Kiswendsida, Bex Marie, Corvilain Bernard, Daumerie Chantal, Decallonne Brigitte, Gruson Damien, Lapauw Bruno, Reyes Rodrigo Moreno, Petrossians Patrick, Poppe Kris, Van den Bruel Annick, Unuane David
Dátum:2022
ISSN:1756-6614
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thyroid Research. - 15 : 1 (2022), p. 1-10. -
További szerzők:Attanasio, Roberto Hegedűs László Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Papini, Enrico Perros, Petros Sawadogo, Kiswendsida Bex, Marie Corvilain, Bernard Daumerie, Chantal Decallonne, Brigitte Gruson, Damien Lapauw, Bruno Reyes, Rodrigo Moreno Petrossians, Patrick Poppe, Kris Van den Bruel, Annick Unuane, David
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

5.

001-es BibID:BIBFORM115438
035-os BibID:(cikkazonosító)40 (scopus)85173593022 (wos)001082009400001
Első szerző:Cassemiro, Jessica F.
Cím:Use of thyroid hormones in hypothyroid and euthyroid patients : a 2022 THESIS questionnaire survey of members of the Latin American Thyroid Society (LATS) / Cassemiro Jessica F., Ilera Veronica, Batalles Stella, Reyes Adriana, Nagy Endre V., Papini Enrico, Perros Petros, Hegedüs Laszlo, Ramos Helton Estrela
Dátum:2023
ISSN:1756-6614
Megjegyzések:Purpose Inconsistencies in the medical management of hypothyroidism have been reported between endocrinologists in different countries. This study aimed to identify the attitudes of Latin America thyroid specialists towards the use of thyroid hormones. Methods Online survey of members of the Latin America Thyroid Society. Results 81/446 (18.2%) completed the questionnaire. Levothyroxine (LT4) was the initial treatment of choice for all respondents. 56.8% would consider LT4 use in biochemically euthyroid patients: infertile women with elevated anti-thyroid antibodies (46.9%), resistant depression (17.3%) and growing goiter (12%). Most respondents preferred tablets (39.5%) over liquid formulations (21.0%) or soft gel capsules (22.2%) and would not consider switching formulations in patients with persistent symptoms. 39.5% would never use LT4+liothyronine (LT3) combination therapy in symptomatic euthyroid patients, due to low quality evidence for benefit. 60.5% reported that persistence of symptoms despite normal TSH is rare (below 5% of patients) and its prevalence has been stable over the last five years. Psychosocial factors (84.0%), comorbidities (86.4%) and the patient unrealistic expectation (72.8%) were considered the top three explanations for this phenomenon. Conclusion LT4 tablets is the treatment of choice for hypothyroidism. A significant proportion of respondents would use LT4 in some groups of euthyroid individuals, contrasting the recommendations of the major clinical practice guideline indications. LT4+LT3 combination treatment in euthyroid symptomatic patients was considered by nearly 50%. Practices based on weak or absent evidence included use of thyroid hormones for euthyroid subjects by 56.8% of respondents and use of LT4+LT3 treatment by 60.5% of respondents for patients with persistent symptoms. In contrast to many European countries, LATS respondents report a low and unchanged proportion of dissatisfied patients over the last five years.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thyroid Research. - 16 : 1 (2023), p. 1-9. -
További szerzők:Ilera, Veronica Batalles, Stella Reyes, Adriana Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Papini, Enrico Perros, Petros Hegedűs László Dávid (1992-) (PhD hallgató) Ramos, Helton Estrela
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

6.

001-es BibID:BIBFORM102792
035-os BibID:(cikkazonosító)e220078
Első szerző:Erdei Annamária (belgyógyász)
Cím:Non-surgical orbital decompression using diuresis in dysthyroid optic neuropathy : a case report / Erdei Annamaria, Gazdag Annamaria, Ujhelyi Bernadett, Nagy Edit B., Berenyi Ervin, Berta Eszter, Steiber Zita, Barna Sandor, Mezosi Emese, Bodor Miklos, V. Nagy Endre
Dátum:2022
ISSN:2235-0640 2235-0802
Megjegyzések:Introduction: Dysthyroid optic neuropathy (DON) is a rare, severe form of thyroid eye disease, in which decreased visual acuity is accompanied by characteristic MRI findings. The treatment of DON has always been a challenge. Case presentation: In a patient in whom visual acuity deteriorated on the left eye, mannitol 20% 200 mL followed by furosemide 40 mg 6 h later, administered daily, were initiated on the day of admission. Visual function by ophthalmology methods, and orbital compartment volumes and water content by MRI were followed. Intravenous diuretics resulted in an immediate therapeutic response. Visual acuity improved from 20/50 to 20/25 after 2 days of treatment. MRI revealed decreasing water content of both the muscle and connective tissue compartments without any volume changes. Subsequently, corticosteroids and orbital irradiation were started. Orbital decompression surgery was not required. Discussion/conclusion: Edematous swelling of orbital tissues is an established contributor of local pressure increase in thyroid eye disease. Diuretics reduce orbital pressure and, if confirmed by others, may be useful additions to the standard of care in sight-threatening DON.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
MRI
diuretics
dysthyroid optic neuropathy
thyroid eye disease
Megjelenés:European Thyroid Journal. - 11 : 5 (2022), p. 1-10. -
További szerzők:Gazdag Annamária (1979-) (belgyógyász) Ujhelyi Bernadett (1981-) (szemész) Nagy Edit B. Berényi Ervin (1964-) (radiológus) Berta Eszter (1980-) (belgyógyász) Steiber Zita (1977-) (orvos, szemész) Barna Sándor (1982-) (kutató orvos) Mezősi Emese Bodor Miklós (1969-) (belgyógyász, endokrinológus) Nagy Endre V. (1957-) (belgyógyász, endokrinológus)
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

7.

001-es BibID:BIBFORM094512
035-os BibID:(WoS)000556900900001 (Scopus)85090899904
Első szerző:Ittermann, Till
Cím:Standardized Map of Iodine Status in Europe / Till Ittermann, Diana Albrecht, Petra Arohonka, Radovan Bilek, Joao J. de Castro, Lisbeth Dahl, Helena Filipsson Nystrom, Simona Gaberscek, Eduardo Garcia-Fuentes, Monica L. Gheorghiu, Alicja Hubalewska-Dydejczyk, Sandra Hunziker, Tomislav Jukic, Borislav Karanfilski, Seppo Koskinen, Zvonko Kusic, Venjamin Majstorov, Konstantinos C. Makris, Kostas B. Markou, Christa Meisinger, Neda Milevska Kostova, Karen R. Mullen, Endre V. Nagy, Valdis Pirags, Gemma Rojo-Martinez, Mira Samardzic, Ljiljana Saranac, Ieva Strele, Michael Thamm, Ișik Top, Malgorzata Trofimiuk-Müldner, Belgin Ünal, Liisa Valsta, Lluis Vila, Paolo Vitti, Benjamin Winter, Jayne V. Woodside, Katja Zaletel, Vaclav Zamrazil, Michael Zimmermann, Iris Erlund, Henry Völzke
Dátum:2020
ISSN:1050-7256
Tárgyszavak:Orvostudományok Egészségtudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thyroid. - 30 : 9 (2020), p. 1346-1354. -
További szerzők:Albrecht, Diana Arohonka, Petra Bilek, Radovan Castro, Joao J. de Dahl, Lisbeth Filipsson Nystrom, Helena Gaberšček, Simona Garcia-Fuentes, Eduardo Gheorghiu, Monica L. Hubalewska-Dydejczyk, Alicja Hunziker, Sandra Jukic, Tomislav Karanfilski, Borislav Koskinen, Seppo Kusić, Zvonko Majstorov, Venjamin Makris, Konstantinos Markou, Kostas B. Meisinger, Christa Milevska Kostova, Neda Mullen, Karen R. Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Pĩrãgs, Valdis Rojo-Martinez, Gemma Samardzic, Mira Saranac, Ljiljana Strele, Ieva Thamm, Michael Top, Ișik Trofimiuk-Müldner, Malgorzata Ünal, Belgin Valsta, Liisa Vila, Lluis Vitti, Paolo Winter, Benjamin Woodside, Jayne Valerie Zaletel, Katja Zamrazil, Vaclav Zimmermann, Michael B. Erlund, Iris Völzke, Henry
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

8.

001-es BibID:BIBFORM091405
035-os BibID:(WoS)000586704600001 (Scopus)85099767801
Első szerző:Nagy Endre V. (belgyógyász, endokrinológus)
Cím:New Formulations of Levothyroxine in the Treatment of Hypothyroidism : trick or Treat? / Nagy Endre V., Perros Petros, Papini Enrico, Katko Monika, Hegedüs Laszlo
Dátum:2021
ISSN:1050-7256
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thyroid. - 31 : 2 (2021), p. 193-201. -
További szerzők:Perros, Petros Papini, Enrico Katkó Mónika (1980-) (biológus) Hegedüs László
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

9.

001-es BibID:BIBFORM041193
Első szerző:Nagy Endre V. (belgyógyász, endokrinológus)
Cím:The Thyroid Gland and Beyond / Nagy V. Endre
Dátum:2001
ISSN:1050-7256
Tárgyszavak:Orvostudományok Klinikai orvostudományok levél
Megjelenés:Thyroid. - 11 : 12 (2001), p. 1199-1200. -
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

10.

001-es BibID:BIBFORM083021
Első szerző:Negro, Roberto
Cím:Use of Thyroid Hormones in Hypothyroid and Euthyroid Patients : the 2019 Italian Survey / Negro Roberto, Attanasio Roberto, Nagy Endre V., Papini Enrico, Perros Petros, Hegedüs Laszlo
Dátum:2019
ISSN:2235-0640 2235-0802
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:European Thyroid Journal. - 9 : 1 (2019), p. 1-7. -
További szerzők:Attanasio, Roberto Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Papini, Enrico Perros, Petros Hegedüs László
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

11.

001-es BibID:BIBFORM119085
035-os BibID:(WoS)000979722700001 (Scopus)85163178290
Első szerző:Perros, Petros
Cím:Hypothyroidism and Somatization : results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey / Petros Perros, Endre Vezekenyi Nagy, Enrico Papini, Christina Maria Van Der Feltz-Cornelis, Anthony Peter Weetman, Harriet Alexandra Hay, Juan Abad-Madroñero, Amy Johanna Tallett, Megan Bilas, Peter Lakwijk, Alan J. Poots, Laszlo Hegedűs
Dátum:2023
ISSN:1050-7256
Megjegyzések:Background: Between 10% and 15% of hypothyroid patients experience persistent symptoms despite achieving biochemical euthyroidism. Unexplained persistent symptoms can be a sign of somatization. This is associated with distress and high health care resource use and can be classified as somatic symptom disorder (SSD). Prevalence rates for SSD differ depending on classification criteria and how they are ascertained, varying between 4% and 25%. As this has not been studied in hypothyroid patients before, the aim of this study was to document somatization in people with hypothyroidism and to explore associations with other patient charac- teristics and outcomes. Methods: Online, multinational cross-sectional survey of individuals with self-reported, treated hypothyroid- ism, which included the validated Patient Health Questionnaire-15 (PHQ-15) for assessment of somatization. Chi-squared tests with the Bonferroni correction were used to explore outcomes for respondents with a PHQ-15 score œ10 (probable somatic symptom disorder [pSSD]) versus a PHQ-15 score <10 (absence of SSD). Results: A total of 3915 responses were received, 3516 of which contained the valid PHQ-15 data (89.8%). The median score was 11.3 (range 0?30 [confidence interval 10.9?11.3]). The prevalence of pSSD was 58.6%. Associations were found between pSSD and young age ( p < 0.001), women ( p < 0.001), not working ( p < 0.001), having below average household income ( p < 0.001), being treated with levothyroxine (LT4) (rather than combination of LT4 and L-triiodothyronine [LT3], LT3 alone, or desiccated thyroid extract) ( p < 0.001), expression of the view that the thyroid medication taken did not control the symptoms of hypo- thyroidism well ( p < 0.001), and with number of comorbidities ( p < 0.001). pSSD was associated with re- spondent attribution of most PHQ-15 symptoms to the hypothyroidism or its treatment ( p < 0.001), dissatisfaction with care and treatment of hypothyroidism ( p < 0.001), a negative impact of hypothyroidism on daily living ( p < 0.001), and with anxiety and low mood/depression ( p < 0.001). Conclusions: This study demonstrates a high prevalence of pSSD among people with hypothyroidism and associations between pSSD and negative patient outcomes, including a tendency to attribute persistent symp- toms to hypothyroidism or its treatment. SSD may be an important determinant of dissatisfaction with treatment and care among some hypothyroid patients.
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
hypothyroidism
somatization
questionnaire
survey
levothyroxine
L-triiodothyronine
Megjelenés:Thyroid. - 33 : 8 (2023), p. 927-939. -
További szerzők:Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Papini, Enrico Feltz-Cornelis, Christina Maria Van Der Weetman, Anthony Peter Hay, Harriet Alexandra Abad-Madronero, Juan Tallett, Amy Johanna Bilas, Megan Lakwijk, Peter Poots, Alan J. Hegedüs László
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:

12.

001-es BibID:BIBFORM105771
035-os BibID:(scopus)85140857010 (wos)000862864000001
Első szerző:Perros, Petros
Cím:The Impact of Hypothyroidism on Satisfaction with Care and Treatment and Everyday Living : Results from E-Mode Patient Self-Assessment of Thyroid Therapy, a Cross-Sectional, International Online Patient Survey / Perros Petros, Hegedüs Laszlo, Nagy Endre Vezekenyi, Papini Enrico, Hay Harriet Alexandra, Abad-Madronero Juan, Tallett Amy Johanna, Bilas Megan, Lakwijk Peter, Poots Alan J.
Dátum:2022
ISSN:1050-7256
Tárgyszavak:Orvostudományok Klinikai orvostudományok idegen nyelvű folyóiratközlemény külföldi lapban
folyóiratcikk
Megjelenés:Thyroid. - 32 : 10 (2022), p. 1158-1168. -
További szerzők:Hegedüs László Nagy Endre V. (1957-) (belgyógyász, endokrinológus) Papini, Enrico Hay, Harriet Alexandra Abad-Madronero, Juan Tallett, Amy Johanna Bilas, Megan Lakwijk, Peter Poots, Alan J.
Internet cím:Szerző által megadott URL
DOI
Intézményi repozitóriumban (DEA) tárolt változat
Borító:
Rekordok letöltése1 2 
Corvina könyvtári katalógus v8.2.27 © 2023 Monguz kft. Minden jog fenntartva.